Quote:
Originally Posted by KC_Lee
So in layman's terms, the variants are not a large issue and the available vaccines will address these variants? Seriously asking here, not being snarky, genuinely asking this.
|
The vaccines produce a strong response and seeing as they produce not only polyclonal antibodies (recognize and bind to different spots on spike protein so a single point mutation won't be a huge problem) but a strong T cell response, yeah, at this point the variants shouldn't be an issue.
If or until they have full mutations in the spike protein, we're fine.